Rula Zain

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Top Venues

European journal of haematology

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Carl Inge Edvard Smith, Rula Zain
Reduced clone size upon BTK inhibitor resistance mutations relates to toxicity caused by inherited PLCG2 gain-of-function variations. European journal of haematology 113 (1) (2024)
Hernando Yesid Estupiñan Velasquez, Thibault Bouderlique, Chenfei He, Anna Berglöf, Andrea Cappelleri, Nicolai Sebastian Frengen, Rula Zain, Mikael C I Karlsson, Robert Månsson, Carl Inge Edvard Smith
In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function. Blood advances 8 (8) (2024)
Hernando Yesid Estupiñan Velasquez, Thibault Bouderlique, Chenfei He, Anna Berglöf, Andrea Cappelleri, Nicolai Sebastian Frengen, Rula Zain, Mikael C I Karlsson, Robert Månsson, Carl Inge Edvard Smith
In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function. Blood advances (2024)
Hernando Yesid Estupiñan Velasquez, Thibault Bouderlique, Chenfei He, Anna Berglöf, Andrea Cappelleri, Nicolai Sebastian Frengen, Rula Zain, Mikael C I Karlsson, Robert Månsson, Carl Inge Edvard Smith
In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function. Blood advances 8 (8) (2024)
Hernando Yesid Estupiñan Velasquez, Thibault Bouderlique, Chenfei He, Anna Berglöf, Andrea Cappelleri, Nicolai Sebastian Frengen, Rula Zain, Mikael C I Karlsson, Robert Månsson, Carl Inge Edvard Smith
In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function. Blood advances 8 (8) (2024)
Carl Inge Edvard Smith, Rula Zain
Reduced clone size upon BTK inhibitor resistance mutations relates to toxicity caused by inherited PLCG2 gain-of-function variations. European journal of haematology (2024)
Carl Inge Edvard Smith, Rula Zain
Reduced clone size upon BTK inhibitor resistance mutations relates to toxicity caused by inherited PLCG2 gain-of-function variations. European journal of haematology 113 (1) (2024)
Aishath Naeem, Filippo Utro, Qing Wang, Justin Cha, Mauno Vihinen, Stephen P Martindale, Yinglu Zhou, Yue Ren, Svitlana Tyekucheva, Annette S Kim, Stacey M Fernandes, Gordon Saksena, Kahn Rhrissorrakrai, Chaya Levovitz, Brian P Danysh, Kara Slowik, Raquel A Jacobs, Matthew S Davids, James A Lederer, Rula Zain, Carl Inge Edvard Smith, Ignaty Leshchiner, Laxmi Parida, Gad Getz, Jennifer R Brown
Pirtobrutinib Targets BTK C481S in Ibrutinib-Resistant CLL but Second-Site BTK Mutations Lead to Resistance. Blood advances (2022)
Lisa Blixt, Gordana Bogdanovic, Marcus Buggert, Yu Gao, Sophia Hober, Katie Healy, Hemming Johansson, Christian Kjellander, Sára Mravinacová, Sandra Muschiol, Peter Nilsson, Marzia Palma, Elisa Pin, Carl Inge Edvard Smith, Olga Stromberg, Margaret Sällberg Chen, Rula Zain, Lotta Hansson, Anders Österborg
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients. Leukemia (2021)
Jeremy P Bost, Osama Saher, Daniel Hagey, Doste R Mamand, Xiuming Liang, Wenyi Zheng, Giulia Corso, Oskar Gustafsson, André Görgens, Ci Edvard Smith, Rula Zain, Samir El Andaloussi, Dhanu Gupta
Growth Media Conditions Influence the Secretion Route and Release Levels of Engineered Extracellular Vesicles. Advanced healthcare materials (2021)
Hernando Yesid Estupiñan Velasquez, Qing Wang, Anna Berglöf, Gerard C P Schaafsma, Yuye Shi, Litao Zhou, Dara K Mohammad, Liang Yu, Mauno Vihinen, Rula Zain, Carl Inge Edvard Smith
BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib. Leukemia 35 (5) (2021)
Rula Zain, Carl Inge Edvard Smith
Targeted Oligonucleotides for Treating Neurodegenerative Tandem Repeat Diseases. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 16 (2) (2020)
Y Vladimir Pabon-Martinez, You Xu, Alessandra Villa, Karin E Lundin, Sylvain Geny, Chi-Hung Nguyen, Erik B Pedersen, Per Trolle Jørgensen, Jesper Wengel, Lennart Nilsson, Carl Inge Edvard Smith, Rula Zain
LNA effects on DNA binding and conformation: from single strand to duplex and triplex structures. Scientific reports 7 (1) (2017)